| Product Code: ETC8848402 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for peripheral artery disease (PAD) treatment in the Philippines is driven by the increasing number of individuals suffering from poor circulation due to diabetes and hypertension. Diagnostic advancements, including Doppler ultrasound and angiography, have improved early detection and treatment outcomes. The availability of novel drugs, surgical procedures like bypass grafting, and non-invasive treatments such as lifestyle modifications are fueling market growth. Government healthcare initiatives focusing on cardiovascular health and increased investments in healthcare infrastructure further support market development.
The prevalence of peripheral artery disease (PAD) in the Philippines is growing due to the increasing number of individuals suffering from risk factors such as diabetes, obesity, and smoking. The growing awareness of PAD, particularly its links to other cardiovascular diseases, has led to more people seeking treatment and diagnosis. The rise of advanced medical technology for early detection, including digital subtraction angiography and magnetic resonance imaging (MRI), has enhanced the diagnosis process. Moreover, the availability of new drug therapies and minimally invasive surgical procedures has improved treatment outcomes, further driving market growth.
Peripheral Artery Disease (PAD) continues to be underdiagnosed and undertreated in the Philippines due to the lack of awareness and limited access to vascular health specialists. Many patients are unable to afford the advanced diagnostic tools and treatments required for PAD, leading to delayed interventions and worsened health outcomes. There is also a need for more comprehensive public health campaigns to educate the population on risk factors such as smoking, diabetes, and high blood pressure, which contribute to PAD development. The shortage of trained vascular surgeons and specialists is another key challenge that limits effective treatment.
Investing in the treatment of peripheral artery disease (PAD) through surgical interventions, stents, and angioplasty technologies presents significant opportunities for both local and international investors. The growing number of patients requiring treatment creates a favorable environment for investments in specialized medical centers, diagnostic imaging tools, and vascular health startups. Collaborating with healthcare providers to introduce new, minimally invasive procedures can offer high returns in this sector.
Similar to PAD policies, the government promotes public awareness campaigns on risk factors like smoking and diabetes. Regulations ensure that medical devices used for diagnosing and treating peripheral artery disease meet safety standards. Government hospitals are equipped with better facilities to handle vascular conditions under the UHC framework.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Peripheral Artery Disease Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Peripheral Artery Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Peripheral Artery Disease Market - Industry Life Cycle |
3.4 Philippines Peripheral Artery Disease Market - Porter's Five Forces |
3.5 Philippines Peripheral Artery Disease Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Philippines Peripheral Artery Disease Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Philippines Peripheral Artery Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of risk factors such as diabetes, hypertension, and obesity in the Philippines |
4.2.2 Growing awareness about peripheral artery disease (PAD) among healthcare professionals and patients |
4.2.3 Technological advancements in minimally invasive procedures for PAD treatment |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities in remote areas of the Philippines |
4.3.2 High cost associated with PAD diagnosis and treatment |
4.3.3 Lack of skilled healthcare professionals specializing in PAD management |
5 Philippines Peripheral Artery Disease Market Trends |
6 Philippines Peripheral Artery Disease Market, By Types |
6.1 Philippines Peripheral Artery Disease Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Peripheral Artery Disease Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Philippines Peripheral Artery Disease Market Revenues & Volume, By Devices, 2021- 2031F |
6.1.4 Philippines Peripheral Artery Disease Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2 Philippines Peripheral Artery Disease Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Philippines Peripheral Artery Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.2.3 Philippines Peripheral Artery Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
7 Philippines Peripheral Artery Disease Market Import-Export Trade Statistics |
7.1 Philippines Peripheral Artery Disease Market Export to Major Countries |
7.2 Philippines Peripheral Artery Disease Market Imports from Major Countries |
8 Philippines Peripheral Artery Disease Market Key Performance Indicators |
8.1 Average wait time for PAD diagnosis and treatment |
8.2 Number of PAD screening programs implemented nationwide |
8.3 Patient satisfaction with PAD treatment options offered |
8.4 Adoption rate of minimally invasive procedures for PAD treatment |
8.5 Percentage of healthcare professionals trained in PAD management |
9 Philippines Peripheral Artery Disease Market - Opportunity Assessment |
9.1 Philippines Peripheral Artery Disease Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Philippines Peripheral Artery Disease Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Philippines Peripheral Artery Disease Market - Competitive Landscape |
10.1 Philippines Peripheral Artery Disease Market Revenue Share, By Companies, 2024 |
10.2 Philippines Peripheral Artery Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |